the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
03 January 2024 – 23andMe is a personal genomics company out of South San Francisco, It is best known for providing a direct-to-consumer (DTC) genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism …
November 08, 2018 – The American Food and Drug Administration (FDA) has just authorized the first direct-to-consumer test for detecting genetic variants in genes that may govern the metabolism of drugs in individual patients. Thus, FDA permits marketing, with special controls, the …
March 31, 2018 – Are patients ready for direct-to-consumer genetic testing? This was the very important and central question that came up in the article by Matt Smith on Medscape, published March 29, 2018. Since thasso is all about theragenomic …
Direct-to-Consumer Genetic Testing: Are Patients Ready? Read more »
June 25, 2014 -The genetics startup 23andMe said on Friday it is one step closer to resuming sales of its full-fledged health product, with the U.S. Food and Drug Administration accepting its first health report for review. The home genetics …
Genetics Startup 23andMe takes Step on Path to FDA Approval Read more »